Lab Members

Joseph Aceves, formerly of California State University, Northridge (CSUN), is a research associate in the Medina-Kauwe Lab at Cedars-Sinai. He uses molecular dynamics simulations to study the HER3 receptor and its role in triple-negative breast cancer (TNBC). Joseph focuses on understanding the HPK2.0 nanobioparticle's mechanisms to advance it as a targeted TNBC treatment. He brings a strong interest in de novo protein design, structural biology, and targeted nanotherapies to our team, helping us reshape the future of cancer care.

Amirhesam Babajani, MD, is a postdoctoral scientist in the Cedars-Sinai Department of Biomedical Sciences. His research focuses on exosome-based delivery systems for targeted therapy of HER3-positive tumors. His work also spans stem cell therapies, placental biology, drug delivery platforms and tumor biology, with the goal of improving patient outcomes.

Nelyda Gonzalez-Almeyda is a Laboratory Manager and Research Associate II in the Medina-Kauwe Laboratory. She oversees a team of postdoctoral scientists, graduate students and research associates while developing and implementing standard operating procedures, mentoring staff, coordinating multi-institutional collaborations and driving experimental research to advance novel protein-based nanobioparticles for targeted cancer therapies.

Kristin Ishaya, a research associate in the Medina-Kauwe Lab, explores molecular mechanisms driving cancer progression, including tumor metabolism, immune signaling and the tumor microenvironment. She is dedicated to advancing innovative, targeted nanotherapeutics that overcome treatment resistance to improve patient outcomes. Kristin brings a collaborative, thoughtful approach to her work and enjoys mentoring others. Outside the lab, she draws strength from her Assyrian heritage and loves painting, hiking and exploring new restaurants. She always strives to create a positive, supportive environment for you and our community.

Sun Woo Kim is a PhD student in the Medina-Kauwe Lab studying the delivery of novel STAT3 inhibitors with the HER3-honing protein (HPK) against triple negative breast cancer (TNBC). He is interested in disease modeling and understanding drug delivery in various cancer models.

Abigail Wiesenthal is a Research Associate I in the Medina-Kauwe Laboratory, where she supports research on therapeutic delivery systems. She contributes to a range of projects and assists with experimental work across the lab, helping advance studies on cellular entry and intracellular processes. She also plays a key role in supporting daily lab operations and collaborating with team members.